Doctorglasses Chain Co

Doctorglasses Chain Co Equity Growth

The Year-over-Year Equity Growth of Doctorglasses Chain Co (300622.SZ) as of Nov 11, 2026 is 19.40 %. In the previous year, Year-over-Year Equity Growth was -3.56 % — a change of -644.67% (higher).

Equity Growth

19.40 %

YoY

-644.67%

Last updated:

Year-over-Year Equity Growth of Doctorglasses Chain Co is 2025 19.40 % . Year-over-Year Equity Growth of Doctorglasses Chain Co was 2024 -3.56 % . It decreases by -644.67% higher compared to the previous year.

The Doctorglasses Chain Co Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
11.15 CNY
Jan 1, 2019
12.71 CNY
Jan 1, 2020
7.28 CNY
Jan 1, 2021
8.03 CNY
Jan 1, 2022
3.93 CNY
Jan 1, 2023
15.35 CNY
Jan 1, 2024
-3.56 CNY
Jan 1, 2025
19.40 CNY
The Doctorglasses Chain Co Equity Growth history
YEAREquity GrowthYoY
19.40 %-644.67%
-3.56 %-123.21%
15.35 %+290.26%
3.93 %-51.03%
8.03 %+10.31%
7.28 %-42.69%
12.71 %+13.95%
11.15 %-86.83%
84.66 %+1,540.07%
5.16 %-361.03%
-1.98 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Doctorglasses Chain Co Stock analysis

What does Doctorglasses Chain Co do? Doctorglasses Chain Co., Ltd. generates revenue through its chain of optical retail stores offering frames, lenses, sunglasses, reading glasses, contact lenses, and care solutions, alongside optometry and optics services. The company operates under the brands President optical, Doctor’s Glasses, zele, and Tong, selling products via direct stores, e-commerce, and wholesale channels. Its primary customer segments include individuals seeking eyewear solutions and optometry services, with a focus on retail and online sales channels. The firm’s product portfolio spans prescription and non-prescription eyewear, including specialized options like reading glasses and contact lenses, supported by care solutions for lens maintenance. Brands such as President optical and Doctor’s Glasses target diverse consumer segments, while zele and Tong cater to specific market niches. Sales through direct stores and e-commerce platforms drive the majority of revenue, complemented by wholesale distribution to other retailers. Doctorglasses Chain Co., Ltd. serves both individual consumers and business clients through its retail and wholesale models. The company’s revenue streams are derived from the sale of eyewear products and associated services, with a strong emphasis on brand-specific product lines. Direct store sales and e-commerce represent the most significant distribution channels, ensuring broad market coverage across its operational regions. Doctorglasses Chain Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Doctorglasses Chain Co stock

Year-over-Year Equity Growth of Doctorglasses Chain Co is 19.40 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Doctorglasses Chain Co since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Doctorglasses Chain Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Doctorglasses Chain Co

All Key Metrics — Doctorglasses Chain Co